The hypothalamic-pituitary-adrenal axis and neuroendocrine responses to stress

Handbook of Neuroendocrinology

Volumn , Issue , 2012, Pages 175-196

  Aguilera, Greti ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882826345     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-375097-6.10008-3     Document Type: Chapter

References (149)

1. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007, 87:873-904.
2. Ulrich-Lai Y.M., Herman J.P. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 2009, 10:397-409.
3. Aguilera G. Regulation of Pituitary ACTH Secretion During Chronic Stress Frontiers in Neuroendocrinology. 1994, 15:321-350.
4. Antoni F.A. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev. 1986, 7:351-378.
5. Akana S.F., Dallman M.F. Chronic cold in adrenalectomized, corticosterone (B)-treated rats: facilitated corticotropin responses to acute restraint emerge as B increases. Endocrinology. 1997, 138:3249-3258.
6. Swanson L.W., Sawchenko P.E. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Ann Rev NeuroSci. 1983, 6:269-324.
7. Antoni F.A. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol. 1993, 14:76-122.
8. Palkovits M, BaffiJ, Pacak K The role of ascending neuronal pathways in stress-induced release of noradrenaline in the hypothalamic paraventricular nucleus of rats. J Neuroendocrinol. 1999, 11:529-539.
9. Swanson L., Sawchenko P., Lind R., Rho J.H. The CRH motoneuron: differential peptide regulation in neurons with possible synaptic, paracrine, and endocrine outputs. Ann NY Acad Sci. 1987, 512:12-23.
10. Bale T.L., Vale W.W. CRF and CRF Receptors: Role in stress responsivity and other behaviors. Ann Rev Pharmacol Toxicol. 2004, 44:525-557.
11. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology. 1983, 36:165-186.
12. Murase M., Uemura T., Kondoh Y., Funabashi T., Hirahara F. Role of corticotropin-releasing hormone in ovarian steroidogenesis. Endocrine. 2002, 18:255-260.
13. Perkins A.V., Linton E.A. Identification and isolation of corticotrophin-releasing hormone-positive cells from the human placenta. Placenta. 1995, 16:233-243.
14. Slominsky A., Wortsman J., Pisarchik A., Zbytek B., Linton E.A., Mazurkiewcz J.E., Wei E.T. Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J. 2001, 15:1678-1693.
15. Kuperman Y., Chen A. Urocortins: emerging metabolic and energy homeostasis perspectives. Trends Endocrin Met. 2005, 19:122-129.
16. Bale T., Hoshijima M., Gu Y., Dalton N., Anderson K., Lee K.-F., Rivier J., Chien K., Vale W., Peterson K. The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure. Proc Natl Acad Sci USA. 2004, 101:3697-3702.
17. Perrin M.H., Vale W.W. Corticotropin releasing factor receptors and their ligand family. Ann NY Acad Sci. 1999, 885:312-328.
18. Aguilera G., Nikodemova M., Wynn P.C., Catt K.J. Corticotropin releasing hormone receptors: two decades later. Peptides. 2004, 25:319-329.
19. Luo X., Kiss A., Makara G., Lolait S.J., Aguilera G. Stress-specific regulation of corticotropin releasing hormone receptor expression in the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Neuroendocrinol. 1994, 6:689-696.
20. Wynn P.C., Hauger R.L., Holmes M.C., Millan M.A., Catt K.J., Aguilera G. Brain and pituitary receptors for corticotropin releasing factor: localization and differential regulation after adrenalectomy. Peptides. 1984, 5:1077-1084.
21. Chalmers D.T., Lovenberg T.W., De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci. 1995, 15:6340-6345.
22. Smagin G.N., Heinrichs S.C., Dunn A.J. The role of CRH in behavioral responses to stress. Peptides. 2001, 22:713-724.
23. Potter E., Behan D.P., Linton E.A., Lowry P.J., Sawchenko P.E., Vale W.W. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci USA. 1992, 89:4192-4196.
24. Petraglia F., Potter E., Cameron V.A., Sutton S., Behan D.P., Woods R.J., Sawchenko P.E., Lowry P.J., Vale W. Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. J Clin Endocrinol Metab. 1993, 77:919-924.
25. Karolyi I.J., Burrows H.L., Ramesh T.M., Nakajima M., Lesh J.S., Seong E., Camper S.A., Seasholtz A.F. Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice. Proc Natl Acad Sci USA. 1999, 96:11595-11600.
26. Aguilera G., Subburaju S., Young S., Chen J. The parvocellular vasopressinergic system and responsiveness of the hypothalamic-pituitary-adrenal axis during chronic stress. Progr Brain Res. 2008, 170:29-39.
27. Alescio-Lautier B., Paban V., Soumireu-Mourat B. Neuromodulation of memory in the hippocampus by vasopressin. Eur J Pharmacol. 2000, 405:63-72.
28. Jard S., Barberis C., Audigier S., Tribollet E. Neurohypophyseal hormone receptor systems in brain and periphery. Prog Brain Res. 1987, 72:173-187.
29. Peter J., Burbach H., Adan R.A., Lolait S.J., van Leeuwen F.W., Mezey E., Palkovits M., Barberis C. Molecular neurobiology and pharmacology of the vasopressin/oxytocin receptor family. Cell Mol Neurobiol. 1995, 15:573-595.
30. Lolait S.J., O'Carroll A.M., Brownstein M.J. Molecular biology of vasopressin receptors Ann NY Acad Sci. 1995, 771:273-292.
31. Seibold A., Brabet P., Rosenthal W., Birnbaumer M. Structure and chromosomal localization of the human antidiuretic hormone receptor gene. Am J Hum Genet. 1992, 51:1078-1083.
32. Sugimoto T., Saito M., Mochizuki S., Watanabe Y., Hashimoto S., Kawashima H. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem. 1994, 269:27088-27092.
33. Szot P., Bale T.L., Dorsa D.M. Distribution of messenger RNA for the vasopressin V1a receptor in the CNS of male and female rats. Mol Brain Res. 1994, 24:1-10.
34. Vaccari C., Lolait S.J., Ostrowski N.L. Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain. Endocrinology. 1998, 139:5015-5033.
35. Young L.J., Toloczko D., Insel T.R. Localization of vasopressin (V1a) receptor binding and mRNA in the rhesus monkey brain. J Neuroendocrinol. 1999, 11:291-297.
36. Herman J.P., Schäfer M.K., Watson S.J., Sherman T.G. In situ hybridization analysis of arginine vasopressin gene transcription using intron-specific probes. Mol Endocrinol. 1991, 5:1447-1456.
37. Kovacs K.J., Sawchenko P.E. Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J Neurosci. 1996, 16:262-273.
38. Ma X.M., Aguilera G. Transcriptional responses of the vasopressin and corticotropin-releasing hormone genes to acute and repeated intraperitoneal hypertonic saline injection in rats. Brain Res Mol Brain Res. 1999, 68:129-140.
39. Alexander S.L., Irvine C.H., Donald R.A. Short-term secretion patterns of corticotropin-releasing hormone, arginine vasopressin and ACTH as shown by intensive sampling of pituitary venous blood from horses. Neuroendocrinology. 1994, 60:225-236.
40. Plotsky P.M. Hypophysiotropic regulation of stress-induced ACTH secretion. Adv Exp Med Biol. 1988, 245:65-81.
41. Rivier C.L., Plotsky P.M. Mediation by Corticotropin Releasing Factor (CRF) of adenohypophysial hormone secretion. Ann Rev Physiol. 1986, 48:475-494.
42. Aguilera G. Direct regulation of hypothalamic corticotropin-releasing-hormone neurons by angiotensin II. Neuroendocrinology. 1995, 61:437-444.
43. Aubry J.M., Bartanusz V., Jezova D., Belin D., Kiss J.Z. Single stress induces long-lasting elevations in vasopressin mRNA levels in CRF hypophysiotrophic neurones, but repeated stress is required to modify AVP immunoreactivity. J Neuroendocrinol. 1999, 11:377-384.
44. de Goeij D.C., Kvetnansky R., Whitnall M.H., Jezova D., Berkenbosch F., Tilders F.J. Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. Neuroendocrinology. 1991, 53:150-159.
45. Ma X.M., Lightman S.L., Aguilera G. Vasopressin and corticotropin-releasing hormone gene responses to novel stress in rats adapted to repeated restraint. Endocrinology. 1999, 140:3623-3632.
46. Guardiola-Diaz H.M., Boswell C., Seasholtz A.F. The cAMP-responsive element in the corticotropin-releasing hormone gene mediates transcriptional regulation by depolarization. J Biol Chem. 1994, 269:14784-14791.
47. Nicholson R.C., King B.R., Smith R. Complex regulatory interactions control CRH gene expression. Front Biosci. 2004, 9:32-39.
48. Liu Y., Coello A.G., Grinevich V., Aguilera G. Involvement of transducer of regulated cAMP response element-binding protein activity on corticotropin releasing hormone transcription. Endocrinology. 2010, 151:1109-1118.
49. Conkright M.D., Canettieri G., Screaton R., Guzman E., Miraglia L., Hogenesch J.B., Montminy M. TORCs: Transducers of Regulated CREB activity. Mol Cell. 2003, 12:413-423.
50. Takemori H., Kanematsu M., Kajimura J., Hatano O., Katoh Y., Lin X.Z., Min L., Yamazaki T., Doi J., Okamoto M. Dephosphorylation of TORC initiates expression of the StAR gene. Mol Cell Endocrinol. 2007, 265-266:196-204.
51. Stroth N., Eiden L.E. Stress hormone synthesis in mouse hypothalamus and adrenal gland triggered by restraint is dependent on pituitary adenylate cyclase-activating polypeptide signaling. Neuroscience. 2010, 165:1025-1030.
52. Ma X.M., Levy A., Lightman S.L. Rapid changes of heteronuclear RNA for arginine vasopressin but not for corticotropin releasing hormone in response to acute corticosterone administration. J Neuroendocrinol. 1997, 9:723-728.
53. Shepard J.D., Liu Y., Sassone-Corsi P., Aguilera G. Role of glucocorticoids and cAMP-mediated repression in limiting corticotropin-releasing hormone transcription during stress. J Neurosci. 2005, 25:4073-4081.
54. Molina C.A., Foulkes N.S., Lalli E., Sassone-Corsi P. Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell. 1993, 75:875-886.
55. Liu Y., Aguilera G. Cyclic AMP inducible early repressor mediates the termination of corticotropin releasing hormone transcription in hypothalamic neurons. Cell Mol Neurobiol. 2009, 29:1275-1281.
56. Eipper B.A., Mains R.E. Structure and biosynthesis of pro-adrenocorticotropin/endorphin and related peptides. Endocr Rev. 1980, 1:1-27.
57. Vale W., Rivier C., Brown M.R., Spiess J., Koob G., Swanson L., Bilezikjian L., Bloom F., Rivier J. Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res. 1983, 39:245-270.
58. Autelitano D.J., Lundblud J.R., Blum M., Roberts J.L. Hormonal regulation of POMC gene expression. Ann Rev Physiol. 1989, 51:715-726.
59. Abou-Samra A.B., Harwood J.P., Manganiello V.C., Catt K.J., Aguilera G. Phorbol 12-myristate 13-acetate and vasopressin potentiate the effect of corticotropin-releasing factor on cyclic AMP production in rat anterior pituitary cells. Mechanisms of action. J Biol Chem. 1987, 262:1129-1136.
60. Gillies G.E., Linton E.A., Lowry P.J. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature. 1982, 299:355-357.
61. Levin N., Blum M., Roberts J.L. Modulation of basal and corticotropin-releasing factor-stimulated proopiomelanocortin gene expression by vasopressin in rat anterior pituitary. Endocrinology. 1989, 125:2957-2966.
62. Aguilera G. Corticotropin releasing hormone, receptor regulation and the stress response. Trends Endocrinol Metab. 1998, 9:329-336.
63. Hauger R.L., Aguilera G. Regulation of pituitary corticotropin releasing hormone (CRH) receptors by CRH: interaction with vasopressin. Endocrinology. 1993, 133:1708-1714.
64. Hauger R.L., Millan M.A., Lorang M., Harwood J.P., Aguilera G. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress. Endocrinology. 1988, 123:396-405.
65. Aguilera G., Pham Q., Rabadan-Diehl C. Regulation of pituitary vasopressin receptors during chronic stress: relationship to corticotroph responsiveness. J Neuroendocrinol. 1994, 6:299-304.
66. Roper J.A., O'Carroll A.M., Young W.S., Lolait S.J. The vasopressin Avpr1b receptor: molecular and pharmacological studies. Stress. 2011, 14:98-115.
67. Subburaju S., Aguilera G. Vasopressin mediates mitogenic responses to adrenalectomy in the rat anterior pituitary. Endocrinology. 2007, 148:3102-3110.
68. Childs G.V., Lloyd J., Unabia G., Rougeau D. Growth and secretory responses of enriched populations of corticotropes. Endocrinology. 1989, 125:2540-2549.
69. Lightman S.L., Conway-Campbell B.L. The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Nat Rev Neurosci. 2010, 11:710-718.
70. Buckingham J.C. Glucocorticoids: exemplars of multi-tasking. Br J Pharmacol. 2006, 147(S1):S258-S268.
71. Vegiopoulos A., Herzig S. Glucocorticoids, metabolism and metabolic diseases. Mol Cell Endocrinol. 2007, 275:43-61.
72. Reul Jmhm, de Kloet E.R.D. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 1985, 117:2505-2511.
73. Evanson N.K., Herman J.P., Sakai R.R., Krause. E.G. Nongenomic actions of adrenal steroids in the central nervous system. J Neuroendocrinol. 2010, 22:846-861.
74. Patel P.D., Lopez J.F., Lyons D.M., Burke S., Wallace M., Schatzberg A.F. Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J Psychiat Res. 2000, 34:383-392.
75. Reul J.M.H.M., Gesing A., Droste S., Stec I.S.M., Weber A., Bachmann C., Bilang-Bleuel A., Holsboer F., Linthorst A.C.E. The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. Eur J Pharmacol. 2000, 405:235-249.
76. Aronsson M., Fuxe K., Dong Y., Agnati L.F., Okret S., Gustafsson J.A. Localization of glucocorticoid receptor mRNA in the male rat brain by in situ hybridization. Proc Natl Acad Sci USA. 1988, 85:9331-9335.
77. Cullinan W.E., Herman J.P., Watson S.J. Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. J Comp Neurol. 1993, 332:1-20.
78. Prewitt C.M.F., Herman J.P. Anatomical interactions between the central amygdaloid nucleus and the hypothalamic paraventricular nucleus of the rat: a dual tract-tracing analysis. J Chem Neuroanat. 1998, 15:173-186.
79. Herman J.P., Figueiredo H., Mueller N.K., Ulrich-Lai Y., Ostrander M.M., Choi D.C., Cullinan W.E. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol. 2003, 24:151-180.
80. Pacak K., Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocr Rev. 2001, 22:502-548.
81. Palkovits M., Zaborszky L., Feminger A., Mezey E., Fekete M.I.K., Herman J.P., Kanyicska B., Szabo D. Noradrenergic innervation of the rat hypothalamus: Experimental biochemical and electron microscopic studies. Brain Res. 1980, 191:161-171.
82. Nakade Y., Tsukamoto K., Iwa M., Pappas T.N., Takahashi T. Glucagon like peptide-1 accelerates colonic transit via central CRF and peripheral vagal pathways in conscious rats. Autonom Neurosci. 2007, 131:50-56.
83. Suda T., Tozawa F., Iwai I., Sato Y., Sumitomo T., Nakano Y., Yamada M., Demura H. Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Mol Brain Res. 1993, 18:311-315.
84. Wahlestedt C., Skagerberg G., Ekman R., Heilig M., Sundler F., Neuropeptide Y. (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res. 1987, 417:33-38.
85. Ziegler D.R., Cullinan W.E., Herman J.P. Organization and regulation of paraventricular nucleus glutamate signaling systems: N-methyl-D-aspartate receptors. J Comp Neurol. 2005, 484:43-56.
86. Chen Y., Rex C.S., Rice C., Dube C.M., Gall C.M., Lynch G., Baram T.Z. Correlated memory defects and hippocampal dendritic spine loss after acute stress involve corticotropin-releasing hormone signaling. Proc Natl Acad Sci USA. 2010, 107:13123-13128.
87. McEwen B.S. Stress and hippocampal plasticity. Ann Rev NeuroSci. 1999, 22:105-122.
88. Vyas A., Mitra R., Shankaranarayana Rao B.S., Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci. 2002, 22:6810-6818.
89. Bhatnagar S., Dallman M. Neuroanatomical basis for facilitation of hypothalamic-pituitary-adrenal responses to a novel stressor after chronic stress. Neuroscience. 1998, 84:1025-1039.
90. Bhatnagar S., Huber R., Nowak N., Trotter P. Lesions of the posterior paraventricular thalamus block habituation of hypothalamic-pituitary-adrenal responses to repeated restraint. J Neuroendocrinol. 2002, 14:403-410.
91. Cottrell G.T., Ferguson A.V. Sensory circumventricular organs: central roles in integrated autonomic regulation. Reg Peptides. 2004, 117:11-23.
92. McKinley M.J., McAllen R.M., Davern P., Giles M.E., Penschow J., Sunn N., Oldfield B.J. The sensory circumventricular organs of the mammalian brain. Adv Anat Embryol Cell Biol. 2003, 172:1-122.
93. McKinley M., Allen A., May C., McAllen R., Oldfield B., Sly D., Mendelsohn F. Neural pathways from the lamina terminalis influencing cardiovascular and body fluid homeostasis. Clin Exp Pharmacol Physiol. 2001, 28:990-992.
94. Banks W.A., Obesity Blood-Brain Barrier and Energy Balance 2006, 14:234S-237S.
95. Konner A.C., Klockener T., Bruning J.C. Control of energy homeostasis by insulin and leptin: targeting the arcuate nucleus and beyond. Physiol Behav. 2009, 97:632-638.
96. Mangurian L.P., Walsh R.J., Posner B.I. Prolactin enhancement of its own uptake at the choroid plexus. Endocrinology. 1992, 131:698-702.
97. Torner L., Neumann I.D. The brain prolactin system: involvement in stress response adaptations in lactation. Stress. 2002, 5:249-257.
98. Antoni F.A. Mortyn Jones Memorial Lecture - 1995. Calcium checks cyclic AMP-corticosteroid feedback in adenohypophysial corticotrophs. J Neuroendocrinol. 1996, 8:659-672.
99. Drouin J., Charron J., Gagner J.P., Jeannotte L., Nemer M., Plante R.K., Wrange O. Pro-opiomelanocortin gene: a model for negative regulation of transcription by glucocorticoids. J Cell Biochem. 1987, 35:293-304.
100. Dallman M.F., Akana S.F., Strack A.M., Scribner K.S., Pecoraro N., La Fleur S.E., Houshyar H., Gomez F. Chronic stress-induced effects of corticosterone on brain: direct and indirect. Ann NY Acad Sci. 2004, 1018:141-150.
101. Furay A.R., Bruestle A.E., Herman J.P. The role of the forebrain glucocorticoid receptor in acute and chronic stress. Endocrinology. 2008, 149:5482-5490.
102. Pacak K., Palkovits M., Kvetnansky R., Matern P., Hart C., Kopin I., Goldstein D.S. Catecholaminergic inhibition by hypercortisolemia in the paraventricular nucleus of conscious rats. Endocrinology. 1995, 136:4814-4819.
103. Day H., Campeau S., Watson S.J., Akil H. Expression of alpha(1b) adrenoceptor mRNA in corticotropin-releasing hormone-containing cells of the rat hypothalamus and its regulation by corticosterone. J Neurosci. 1999, 19:10098-10106.
104. Fenoglio K.A., Brunson K.L., vishai-Eliner S., Chen Y., Baram T.Z. Region-specific onset of handling-induced changes in corticotropin-releasing factor and glucocorticoid receptor expression. Endocrinology. 2004, 145:2702-2706.
105. Harbuz M.S., Lightman S.L. Glucocorticoid inhibition of stress-induced changes in hypothalamic corticotrophin-releasing factor messenger RNA and proenkephalin a messenger RNA. Neuropeptides. 1989, 14:17-20.
106. Kovacs K., Kiss J.Z., Makara G.B. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy. Neuroendocrinology. 1986, 44:229-234.
107. Liposits Z., Uht R.M., Harrison R.W., Gibbs F.P., Paull W.K., Bohn M.C. Ultrastructural localization of glucocorticoid receptor (GR) in hypothalamic paraventricular neurons synthesizing corticotropin releasing factor (CRF). Histochemistry. 1987, 87:407-412.
108. Sawchenko PE Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus. Brain Res. 1987, 213-224.
109. Di S., Malcher-Lopes R., Halmos K.C., Tasker J.G. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci. 2003, 23:4850-4857.
110. Wagenmaker E.R., Breen K.M., Oakley A.E., Tilbrook A.J., Karsch F.J. Psychosocial Stress Inhibits Amplitude of Gonadotropin-Releasing Hormone Pulses Independent of Cortisol Action on the Type II Glucocorticoid Receptor. Endocrinology. 2009, 150:762-769.
111. Ferin M. Stress and the reproductive cycle. J Clin Endocrinol Metab. 1999, 84:1768-1774.
112. Tilbrook A.J., Canny B.J., Serapiglia M.D., Ambrose T.J., Clarke I.J. Suppression of the secretion of luteinizing hormone due to isolation/restraint stress in gonadectomised rams and ewes is influenced by sex steroids. J Endocrinol. 1999, 160:469-481.
113. Rivier C., Rivest S. Effect of stress on the activity of the hypothalamic-pituitary-gonadal axis: peripheral and central mechanisms. Biol Reprod. 1991, 45:523-532.
114. Charlton H. Hypothalamic control of anterior pituitary function: a history. J Neuroendocrinol. 2008, 20:641-646.
115. Li X.F., Knox A.M.I., O'Byrne K.T. Corticotrophin-releasing factor and stress-induced inhibition of the gonadotrophin-releasing hormone pulse generator in the female. Brain Res. 2010, 1364:153-163.
116. Campbell R.E., Herbison A.E. Definition of brainstem afferents to gonadotropin-releasing hormone neurons in the mouse using conditional viral tract tracing. Endocrinology. 2007, 148:5884-5890.
117. Keen-Rhinehart E., Michopoulos V., Toufexis D.J., Martin E.I., Nair H., Ressler K.J., Davis M., Owens M.J., NemeroffC.B., Wilson M.E. Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes. Mol Psychiatry. 2009, 14:37-50.
118. Weller K.L., Smith D.A. Afferent connections to the bed nucleus of the stria terminalis. Brain Res. 1982, 232:255-270.
119. Li X.F., Bowe J.E., Kinsey-Jones J.S., Brain S.D., Lightman S.L., O'Byrne K.T. Differential role of corticotrophin-releasing factor receptor types 1 and 2 in stress-induced suppression of pulsatile luteinising hormone secretion in the female rat. J Neuroendocrinol. 2006, 18:602-610.
120. Li X.F., Kinsey-Jones J.S., Cheng Y., Knox A.M.I., Lin Y., Petrou N.A., Roseweir A., Lightman S.L., Milligan S.R., Millar R.P., O'Byrne K.T. Kisspeptin signalling in the hypothalamic arcuate nucleus regulates GnRH pulse generator frequency in the rat. PLoS ONE 2009, 4:e8334.
121. Clarke I.J., Qi Y., Puspita S.I., Smith J.T. Evidence that RF-amide related peptides are inhibitors of reproduction in mammals. Front Neuroendocrinol. 2009, 30:371-378.
122. Kirby E.D., Geraghty A.C., Ubuka T., Bentley G.E., Kaufer D. Stress increases putative gonadotropin inhibitory hormone and decreases luteinizing hormone in male rats. Proc Natl Acad Sci USA. 2009, 106:11324-11329.
123. Breen K.M., Karsch F.J. New insights regarding glucocorticoids, stress and gonadotropin suppression. Front Neuroendocrinol. 2006, 27:233-245.
124. Saketos M., Sharma N., Santoro N.F. Suppression of the hypothalamic-pituitary-ovarian axis in normal women by glucocorticoids. Biol Reproduct. 1993, 49:1270-1276.
125. Li X.F., Mitchell J.C., Wood S., Coen C.W., Lightman S.L., O'Byrne K.T. The effect of oestradiol and progesterone on hypoglycaemic stress-induced suppression of pulsatile luteinizing hormone release and on corticotropin-releasing hormone mRNA expression in the rat. J Neuroendocrinol. 2003, 15:468-476.
126. Jeong K.-H., Jacobson L., Widmaier E.P., Majzoub J.A. Normal suppression of the reproductive axis following stress in corticotropin-releasing hormone-deficient mice. Endocrinology. 1999, 140:1702-1708.
127. Morley J.E. Neuroendocrine control of thyrotropin secretion. Endocr Rev. 1981, 2:396-436.
128. Van den Berghe G. Dynamic neuroendocrine responses to critical illness. Front Neuroendocrinol. 2002, 23:370-391.
129. Weinmann M. Stress-induced hormonal alterations. Crit Care Clin. 2001, 17:1-10.
130. Helmreich D.L., Parfitt D.B., Lu X.Y., Akil H., Watson S.J. Relation between the Hypothalamic-Pituitary-Thyroid (HPT) axis and the Hypothalamic-Pituitary-Adrenal (HPA) axis during repeated stress. Neuroendocrinology. 2005, 81:183-192.
131. Bruhn T., Huang S., Vaslet C., Nillni E. Glucocorticoids modulate the biosynthesis and processing of proThyrotropin-releasing hormone (proTRH). Endocrine. 1998, 9:143-152.
132. De Groef B., Van der Geyten S., Darras V.M., Knhn E.R. Role of corticotropin-releasing hormone as a thyrotropin-releasing factor in non-mammalian vertebrates. Gen Comp Endocrinol. 2006, 146:62-68.
133. NicoloffJ.T., Fisher D.A., Appleman M.D. The role of glucocorticoids in the regulation of thyroid function in man. J Clin Invest. 1970, 49:1922-1929.
134. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000, 52:595-638.
135. García-Tornadu I., Risso G., Perez-Millan M.I., Noain D., Diaz-Torga G., Low M.J., Rubinstein M., Becu-Villalobos D. Neurotransmitter modulation of the GHRH-GH axis. Front Horm Res. 2010, 38:59-69.
136. Raza J., Massoud A.F., Hindmarsh P.C., Robinson I.C., Brook C.G. Direct effects of corticotrophin-releasing hormone on stimulated growth hormone secretion. Clin Endocrinol. 1998, 48:217-222.
137. Casanueva F.F., Burguera B., Muruais C., Dieguez C. Acute administration of corticoids: a new and peculiar stimulus of growth hormone secretion in man. J Clin Endocrinol Metab. 1990, 70:234-237.
138. Casanueva F.F. Depending on the time of administration, dexamethasone potentiates or blocks growth hormone-releasing hormone-induced growth hormone release in man. Neuroendocrinology. 1988, 47:46-49.
139. Karin M., Castrillo J.L., Theill L.E. Growth hormone gene regulation: a paradigm for cell-type-specific gene activation. Trends Genet. 1990, 6:92-96.
140. Katakami H., Arimura A., Frohman L.A. Involvement of hypothalamic somatostatin in the suppression of growth hormone secretion by central corticotropin-releasing factor in conscious male rats. Neuroendocrinology. 1985, 41:390-393.
141. Rivier C., Vale W. Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat. Endocrinology. 1985, 117:2478-2482.
142. Senaris R.M., Lago F., Coya R., Pineda J., Dieguez C. Regulation of hypothalamic somatostatin, growth hormone-releasing hormone, and growth hormone receptor messenger ribonucleic acid by glucocorticoids. Endocrinology. 1996, 137:5236-5241.
143. Smith S.M., Vaughan J.M., Donaldson C.J., Rivier J., Li C., Chen A., Vale W.W. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism. Endocrinology. 2004, 145:5202-5209.
144. Dhillo W.S., Small C.J., Seal L.J., Kim M.S., Stanley S.A., Murphy K.G., Ghatei M.A., Bloom S.R. The hypothalamic melanocortin system stimulates the hypothalamo-pituitary-adrenal axis in vitro and in vivo in male rats. Neuroendocrinology. 2002, 75:209-216.
145. Dimitrov E.L., DeJoseph M.R., Brownfield M.S., Urban J.H. Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity. Endocrinology. 2007, 148:3666-3673.
146. Fekete C., Legradi G., Mihaly E., Tatro J.B., Rand W.M., Lechan R.M. [alpha]-Melanocyte stimulating hormone prevents fasting-induced suppression of corticotropin-releasing hormone gene expression in the rat hypothalamic paraventricular nucleus. NeuroSci Letters. 2000, 289:152-156.
147. Heinrichs S.C., Menzaghi F., Pich E.M., Hauger R.L., Koob G.F. Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res. 1993, 611:18-24.
148. Uehara Y., Shimizu H., Ohtani K., Sato N., Mori M. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes. 1998, 47:890-893.
149. Vrang N., Larsen P.J., Tang-Christensen M., Larsen L.K., Kristensen P. Hypothalamic cocaine-amphetamine regulated transcript (CART) is regulated by glucocorticoids. Brain Res. 2003, 965:45-50.